abrdn UK Smaller Companies Growth Trust plc

HALF YEARLY REPORT FOR THE SIX MONTHS ENDED 31 DECEMBER 2022

Legal Entity Identifier (LEI):  213800UUKA68SHSJBE37

INVESTMENT OBJECTIVE

The Company's objective is to achieve long-term capital growth by investment in UK-quoted smaller companies.

Reference Index

The Company's reference index is the Numis Smaller Companies plus AIM (ex investment companies) Index.

PERFORMANCE HIGHLIGHTS AND FINANCIAL CALENDAR

Financial Calendar

Financial Highlights

Chairman's Statement

Performance

The issues that made the headlines in the first half of 2022, including the war in Ukraine and the cost of living crisis, have persisted. This has made a difficult backdrop against which to be an investor in UK smaller companies and the performance of the Company reflects this. The Company's net asset value ("NAV") total return was -2.2% for the six months to 31 December 2022, while the share price produced a positive total return of 3.3%. The difference between these returns is a consequence of the movement in the discount, which narrowed from 14.6% on 30 June 2022 to 10.0% at the end of the period.

The total return of the Company's reference index, the Numis Smaller Companies plus AIM (ex investment companies) Index (the "Reference Index") was almost exactly half way between these two returns at -0.6%. If we drill into the numbers more closely, we can see that while the NAV fell in value in five of the first six months in 2022, it only fell in three of the months in the second half of the year and most of the negativity was over the summer. This indication of a more stable market environment is welcome, but the UK economy in which our investee companies operate remains fragile.

The Investment Manager's Review provides further information on stock performance and portfolio activity during the period, as well as the Investment Manager's outlook for smaller companies.

Earnings and Dividend

The revenue earnings per share ("EPS") for the six months to 31 December 2022 increased by 24.9% to 5.32p (2021: 4.26p), with underlying dividends per share from investee companies rising by 9.1% compared to the same period last year. This time last year we reported an almost identical increase in EPS and attributed this to the lower prior year figure, a result of the impact of Covid on profitability across the market. This year, we can point to the increase in confidence in the management of investee companies given that they have been able to improve their distributions to shareholders.

The continued recovery in income and earnings is very welcome and, while recognising that there remains a degree of uncertainty in the outlook for the UK economy, the Board has concluded that the earnings forecasts enable it to declare an increased interim dividend of 3.00p per share (2022: 2.70p per share) which will be paid on 14 April 2023 to shareholders on the register on 17 March 2023 with an associated ex-dividend date of 16 March 2023.

Gearing

At the end of the period gearing, net of cash, was 1.1% (30 June 2022: 5.1%). During the period, the Company entered into a new revolving credit facility of £40 million (the "RCF") with The Royal Bank of Scotland International Limited. The RCF has a further uncommitted accordion provision allowing the Company to request an increase, subject to the lender's approval, of up to an additional £25 million. The Company drew £25 million of the RCF on 1 November 2022 and used the proceeds drawn to repay, in full, the former term loan which matured on that date. At 31 December 2022, £25 million was drawn down under the RCF at an interest rate of 4.73%.

Discount Control and Share Buy Backs

At 31 December 2022 the Company's shares were trading at a discount of 10.0% to its NAV per share, including income with debt at fair value. This was narrower than the 14.6% discount at which the shares were trading at the end of June 2022. The Board continues to operate a discount control mechanism which targets a maximum discount of the share price to the cum-income NAV of 8% under normal market conditions.  The width of the discount during the period, which was a feature shared by many of the Company's peers, illustrated the market's aversion to UK smaller companies.  The Company was active in the market on most days and bought back 2.3 million shares (2.5% of the opening issued share capital) at a weighted average price of 466.1p, which equated to an average discount of 12.0%. The accretion to the NAV per share as a result of buy backs was approximately 1.5p.

At the time of writing, the Company's shares are trading at an estimated  discount of 12.5%.

Management Team

After more than 19 years as the portfolio manager to the Company, and 37 years at Standard Life and abrdn, Harry Nimmo retired on 31 December 2022. On behalf of the Board and shareholders, I would like to express my thanks to Harry for all that he has done to make the Company what it is today. While the last 12 months have been hard from a performance perspective, the Company has benefitted hugely from Harry's stewardship over many years. We all wish him well for a long and happy retirement. Harry's successor, Abby Glennie, has been working alongside him on the Company's portfolio for over three years and we are confident that she will build on his long term track record. We look forward to working with her and Amanda Yeaman over the coming years.

Outlook

The UK economy remains very fragile having flatlined over the final quarter of 2022. Some of the most difficult consequences of the pandemic, such as the supply chain issues, have now eased but others, including the squeeze on skilled labour, are set to continue. High energy prices and the cost of living crisis are causing weaker demand in key economic sectors. The forecast recession may well be shallow, but interest rates are not expected to peak until at least August, causing demanding economic conditions for our investee companies for at least the first half of the year and quite likely all of 2023.

That said, the market typically anticipates well ahead and we should expect that this is baked into the share prices of our portfolio companies and that the worst might be behind us. Some of the adverse and often somewhat indiscriminate market reaction to growth companies may well start to reverse. The increased gap between the valuation of smaller UK companies and their large cap brethren also provides scope for a re-rating of smaller companies as the economic backdrop improves.

Whilst mindful of the macro economic backdrop, our fund managers are continuing to determine the shape of the portfolio through their bottom-up stock selection process, which focuses on high quality, strongly financed companies with sustainable growth prospects. The Board, like our fund managers, believes the current period offers significant opportunity to invest in companies with strong growth potential at a relatively low point in their valuation cycle.

Liz Airey
Chairman
2 March 2023

Interim Management Report

Directors' Responsibility Statement

The Directors are responsible for preparing the Half Yearly Financial Report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

-       The condensed set of financial statements has been prepared in accordance with Financial Reporting Standard 104 'Interim Financial Reporting';

-       The Interim Board Report (constituting the interim management report) includes a fair review of the information required by DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and a description of the principal risks and uncertainties for the remaining six months of the year; and

-       The financial statements include a fair review of the information required by DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the first six months of the financial year and that have materially affected the financial position or performance of the Company during that period, and any changes in the related party transactions described in the last Annual Report that could do so.

Principal and Emerging Risks and Uncertainties

The Board regularly reviews the principal and emerging risks and uncertainties faced by the Company together with the mitigating actions it has established to manage the risks. These are set out within the Strategic Report contained within the Annual Report for the year ended 30 June 2022 and comprise the following risk categories:

-       Strategy

-       Investment performance

-       Key person risk

-       Share price

-       Financial instruments

-       Financial obligations

-       Regulatory

-       Operational

-       Geopolitical

The Company's principal risks and uncertainties have not changed materially since the date of the Annual Report and no material change is foreseen in the principal risks over the remainder of the financial year.

Going Concern

The Company's assets consist mainly of equity shares in companies listed on recognised stock exchanges and are considered by the Board to be realisable within a short timescale under normal market conditions. The Board has set overall limits for borrowing and reviews regularly the Company's level of gearing, cash flow projections and compliance with banking covenants. The Board has also reviewed stress testing analysis and considered the liquidity of the portfolio. 

As at 31 December 2022, the Company had a £40 million unsecured revolving credit facility with The Royal Bank of Scotland International Limited which matures on 1 November 2025.  £25 million of the facility was drawn down at the end of the period.

The Directors are mindful of the Principal Risks and Uncertainties summarised above and they believe that the Company has adequate financial resources to continue in operational existence for a period of not less than 12 months from the date of approval of this Report. They have arrived at this conclusion having confirmed that the Company's diversified portfolio of realisable securities is sufficiently liquid and could be used to meet short-term funding requirements were they to arise. The Directors have also reviewed the revenue and ongoing expenses forecasts for the coming year and considered the Company's Condensed Statement of Financial Position as at 31 December 2022 which shows net current liabilities of £6.6 million at that date. Taking all of this into account, the Directors believe that it is appropriate to continue to adopt the going concern basis in preparing the financial statements.

On behalf of the Board
Liz Airey,
Chairman
2March 2023

Investment Manager's Review

The net asset value ("NAV") total return for the Company for the six months to 31 December 2022 was -2.2% while the share price produced a positive total return of 3.3%. By comparison, the UK smaller companies sector as represented by the Numis Smaller Companies plus AIM (ex investment companies) Index (the "Reference Index") delivered a total return of -0.6%. abrdn has managed the Company since 1 September 2003.

Equity Markets

After a very challenging first half of 2022, we had hoped for a more stable backdrop going into this financial year. However, markets have continued to be dominated by top-down macro factors rather than bottom-up company fundamentals. The continued war in Ukraine, combined with the very hawkish pivot of central banks in the US and the UK meant that any hopes for a steady recovery from the pandemic were no longer likely to come to fruition.

Markets suffered a number of macroeconomic shocks, most notably the continued rise of inflation, which has been higher and longer than economists and policy makers were predicting earlier in the year. In the US and UK, the annual rate of inflation reached 40 year highs in 2022. Large increases in the prices of food and energy sparked fears about a 'cost-of-living' crisis and declines in household disposable incomes, with the biggest pinch being felt at lower income tiers given their higher exposure in the mix to energy, food and fuel, which are all highly inflationary. Unemployment rates in the UK have remained low however, helping limit the potential consumer squeeze for now. For businesses, investors worried that inflation would result in higher input costs and potentially lower profit margins leading to a reduction in company earnings.

The UK also saw a great deal of political upheaval with the short-lived appointment of Liz Truss as Prime Minister and her replacement by Rishi Sunak, following her poorly received mini-budget which put further pressure on UK markets. We saw some stability as both Liz Truss and Chancellor Kwarteng were replaced by Rishi Sunak and Jeremy Hunt respectively and they reversed most of their predecessors' actions. This embarrassment for the UK, however, seemed to put a further dampener on overseas investors' appetite to invest in UK equities. We have seen interest rates rise by the most in 33 years, as the government acts to combat the high levels of inflation, but this will also have an effect on disposable incomes for many consumers, given the impact on mortgage payments over time as the cost of their variable-rate loans increases quickly, or as they roll off fixed rates.

In October, analysts delivered the highest proportion of earnings downgrades since June 2020 and the skew across the market cap bands was pronounced. The FTSE 100 Index recorded net upgrades, thanks to the presence of a number of global companies that benefit from a strong US Dollar, especially in the consumer staples groups. In contrast, companies in the FTSE 250 Index suffered twice as many downgrades as upgrades. Encouragingly, however, in the period, the market felt more rational in its share price response to results and earnings changes.

The differing performance of the large and small cap indices is mirrored in fund flows. Large cap funds suffered small outflows during 2022, at approximately 2% of assets under management ("AUM"), but mid-cap funds tracking the FTSE 250 Index saw outflows of approximately 18% of AUM and small cap funds saw outflows of approximately 12%. Small and mid cap fund managers lost assets not because of their own actions but because of the general market movements.

Value stocks continued to perform relatively well during the period, having strongly outperformed quality and growth in the early part of 2022. To some extent, this shift could be seen as a reversal of pandemic trends, when growth companies, such as internet and technology stocks, were in demand. In terms of currencies, the US Dollar was a standout performer, although it started to ease later in the period. The result was a UK market that was essentially divided into two camps. The FTSE 100 Index, with its large exposure to oil & gas, banks and mining companies, as well as overseas earnings, continued to hold up well relative to the FTSE 250 and Small Cap indices.

October and November saw a strong rebound in the FTSE 250 Index, with smaller companies strongly outperforming the FTSE 100 Index over that period. Historically, it has been typical to see the small and mid cap area of the market lead in times of market recovery. Not surprisingly, however, the market strength faded slightly into the turn of the year, with continuing macro uncertainty, inflation remaining stubbornly high and the consumer squeeze really coming to pass, as well as continued earnings downgrades across the smaller companies universe.

Equity markets came to a standstill during the period, and earlier in 2022, with practically no IPOs in the year. Similarly, M&A volumes declined substantially, due mainly to private equity firms deploying less capital than in previous years as well as challenges posed by the rising cost of debt. There were limited bids for UK companies, and no bids for companies in the portfolio.

It is notable that the early part of 2023 has shown more robust consumer spending and sentiment than the market expected, and the Bank of England has softened its outlook on the length and depth of a recession. Even in a recession, there are still opportunities within the market. Stock picking becomes important and our Quality, Growth and Momentum process has historically performed relatively well against a backdrop such as this.

Performance

The period in question was a tough one for our process, and the portfolio underperformed the benchmark as a result, although we were pleased to see better relative performance during the fourth quarter of 2022. Despite a strong understanding across markets since before summer that the UK would enter a recession, it took until October for the market to show any focus on quality of businesses. Whilst across the portfolio we have not been totally immune to macro headwinds or earnings downgrades, we have been very pleased at the earnings resilience of the Company's investments, particularly in the larger holdings.

At the time of writing, in the current top 10 holdings, six had upgrades to earnings expectations when they last reported, with the other four having no changes.

The five leading performers during the period were as follows:

Kainos - The company showed its strong market resilience and pricing power. Despite inflationary pressures, the demand across the corporate sector and government for its services is so strong that it was able to pass on inflation and protect its margins.

4imprint - Demand for promotional products in the US rose as the market recovered from Covid, and in a fragmented market 4imprint took market share aided by its investment in marketing, which drove repeat customers and strong financial returns. The company delivered consistent upgrades to earnings expectations. 

Alpha Financial Markets - This consultant to the asset management industry is beating expectations as it grows both by sector and geographically, particularly into insurance and alternative investments, as well as strongly within the US. It has pricing power to protect itself from inflation and, with the ongoing structural and regulatory burdens on its industries, its services remain consistently in demand.

Ergomed - There has been consistent growth from Ergomed over the past year, with its focus on being exposed to the faster growing segments in the CRO (contract research organisation) market of oncology and rare disease, combining well with the very defensive areas in PrimeVigilance (drug safety monitoring), providing strong revenue visibility.

Diploma - Despite operating in more cyclical industries, Diploma, the added value distributor of technical products and services, has proven that its niches have remained more resilient, it has pricing power, and its value-add proposition helps retain attractive margins.

The five worst performers during the period were as follows:

Hilton Food - The company has experienced disappointing and surprising earnings downgrades where, despite its strong contracts with cost pass through mechanisms, it was unable to pass through all the inflationary elements of high salmon protein pricing. This drove margin and earnings downgrades, but doesn't impact our positive longer term investment case for the company.

Mortgage Advice Bureau - Mortgage Advice Bureau was a victim of Kwasi Kwarteng's mini budget, which had harsh and rapid impacts on the housing market. It saw activity fall sharply, as banks held back mortgage approvals and products due to uncertainty. However, we are confident that market environments are settling down and that Mortgage Advice Bureau, with its market leading proposition, will continue to gain market share.

Alliance Pharma - We are disappointed in what should have been a defensive pharmaceuticals business, with Chinese Covid restrictions hindering exports, disrupted distributor orders, and a Competition Market Authority investigation. We have exited this holding.

Marshalls - Whilst a high quality business in its industry, Marshalls is not exempt from market downturns and has seen consumer spending drive lower demand in its residential exposure. Demand within the infrastructure business remains solid. Marshalls has a strong operational track record, and there is a lot it can do on efficiencies and margin protection in a downturn, which supports our continued holding.

XP Power - The company had a tough year with supply-chain challenges, and margin pressure from cost increases, compounded by losing a US court case related to a historical acquisition. These aspects pushed the balance sheet leverage higher, which was a concern for the market.

Dealing and Activity

Turnover remained modest during the period, in line with longer-term turnover levels.

Four new holdings were added to the portfolio; Paragon Banking, Coats, Craneware and Smart Metering Systems.

Paragon Banking is a specialist buy-to-let lender in the UK, with strong credit quality and resilient stress testing in tougher macro environments. Compared to previous cycles, Paragon has a banking license, and is funded by retail deposits, making it a beneficiary of wider spreads as a result of the increase in interest rates. Paragon is a defensive, well capitalised secured specialist lender benefitting from highly attractive market economics. A structural under supply of housing in the UK, allied to increasing affordability constraints for the would be first time buyer, underscore future rental demand, with professional multi property landlords dominating growth. Paragon is highly capital generative which in turn supports a rolling buy back programme. It has returned capital of approximately £675 million to shareholders since 2015, which is 50% of its current market capitalisation. The valuation remains attractive, with a 5.5% dividend yield.

We added a holding in Coats, a global market leader in the manufacture of sewing thread and supplies. The business has a leading share of more than 20% in the apparel and footwear thread market, partly thanks to its global scale, colour matching technology and longstanding reputation for quality products. Coats has a strong track record of managing its cost base, through increased manufacturing automation, a higher value mix from greater performance materials thread sales, and other self-help initiatives. While the current macroeconomic backdrop could present near term risks, we are positive on the longer term opportunities. Recent investment in inventory management, digitalisation and ESG credentials has driven further market share gains, as an enabler of moving textile industries towards sustainability. The business is poised for the delivery of strategic projects, which look to optimise the portfolio and footprint. The shares yield 2.9%.

Craneware, the Edinburgh-based healthcare technology business, is a leader in the US hospital market for revenue integrity solutions. These are embedded in hospital operational processes, helping improve the financial performance of these organisations. Craneware was co-founded by the CEO, Keith Neilson, in 1999. The business has grown organically and through bolt on acquisitions such as Sentry Data Systems in 2021. Its product development and cross selling opportunities help deliver growth, the revenue model provides strong visibility, and it retains attractive and sustainable margins. The shares yield 1.7%, which is attractive for a growth business in the technology sector.

Smart Metering Systems ("SMS") is a fully integrated energy infrastructure business, which both owns and manages meter assets, energy data, grid-scale batteries and other carbon reduction assets. The meters help consumers manage their energy usage and provide inflation linked and visible revenue streams. Inflation linkage has become particularly valuable in the current macro-economic climate. The ongoing roll out of smart meters is predicted to continue to 2025, providing a long term visible revenue stream, and limited need for additional capital. The newer and potentially high growth part of the business is grid like battery storage. The business has a growing pipeline with a huge forecast demand increase for these assets and SMS is well placed to keep a strong share given relationships and experience. We note the increasing debt levels expected over the next few years (from net cash currently), to fund the battery rollout. This is a business which should be able to support structural debt levels given the revenue generating asset base, as its private peers do. The dividend yield is 3.5%. 

Eleven holdings were exited in the period. Hotel Chocolat suffered from UK consumer weakness, and also stepping back from the expansion in US and Japan (where Covid in particular has been a hindrance to market penetration). This came at a time of investing in capacity, driving strong margin downgrades and hits to earnings. Gooch & Housego has seen earnings downgrades, impacts from labour and supply chain shortages, a change in CEO, and the need for investment. The holding in Intermediate Capital was sold due to concerns over the risks around end market weakness. Jet2 has suffered many macro headwinds in recent years, and with the UK consumer squeeze increasing and pressure on holiday spend in 2023, during a time pricing needs to increase to cover inflationary pressures, we exited this holding for now. Alliance Pharma was exited following trading disappointments, Chinese export issues with Covid, and an investigation against the CEO from many years prior. Big Yellow, the self storage business, is somewhat impacted by weaker housing markets and higher interest rates given its balance sheet. Watkin Jones saw the mini budget impact its forward sales, highlighting to us the lumpiness of the business' revenue, and the lack of contracted visibility in tougher environments. Inspecs was exited after a weak update, where consumer weakness in Germany and France are the most recent pressures. Gear4Music was another consumer casualty, having had a strong Covid period from online dominance. Molten Ventures' shares struggled on the disconnect between private and listed valuations, and the pressures on the growth businesses in which it invests. Lastly, we sold the holding in Moonpig (although we did not fully exit the holding until after the period end) where the progress on the gifting side of the business has been lacklustre, and in a tougher consumer environment we see this remaining challenging in the near term. Moonpig was not a dividend payer.

Significant purchases included topping up holdings in Serica Energy, CVS, 4imprint and Gamma Communications. We trimmed holdings in GB Group, Future, Impax Asset Management, Liontrust Asset Management, Safestore, Sirius Real Estate, Marshalls and Focusrite. Other major sales represented taking profits in the largest holdings, Telecom Plus and Kainos, controlling position sizes as these share prices outperformed.

Sector Exposure

The portfolio is built on a bottom-up basis, whereby we select individual companies based on their fundamental prospects. Sector exposure is therefore an outcome of the stock selection process, rather than being the determinant of which companies are held in the portfolio. The highest sector exposures at the time of writing are Support Services, Media, Financial Services, Software, Leisure Goods and Telecoms. The exposure to Communication Services and Healthcare increased, through performance and top ups. The exposure to Real Estate fell, with reductions in the holdings of companies where we saw cyclical and interest rate risks, whilst the exposure to Consumer Staples fell with a weak performance from Hilton Food, and we reduced the size of that holding. The exposure to Resources remains low, although we did add a holding in Serica Energy in the previous period. We also have limited exposure to the Retail and Real Estate sectors.

Discount

At 31 December 2022 the cum-income discount to NAV stood at 10.0%. The simple average discount for the seven close peers was 8.5%.

Gearing

The level of net gearing at 31 December 2022 was 1.1%. Gearing is likely to remain at or around current levels for the time being, reflecting our more cautious shorter term concerns, but we continue to believe strongly in the medium to long-term prospects for smaller companies. We repaid some of the borrowings during the period, taking a more conservative view towards equity markets over the short term, with the ability to increase gearing again when we see the right opportunity.

Dividends

There was good growth in dividend receipts during the period, aligned with our sentiment above that the reporting overall in the portfolio, and the earnings growth being delivered, remain strong.

It is notable that within the top ten holdings, the rate of dividend growth has accelerated, excluding the outlier of 4imprint which has exceptional growth, having had Covid dividend pauses, and Ergomed, which is the only top 10 holding that doesn't pay a dividend. The other eight names in the top 10 are averaging 26% dividend growth forecasts for 2022.

Ergomed, Watches of Switzerland, Marlowe, Big Technologies, Team 17, Auction Technology and Motorpoint are the only holdings in the portfolio which do not pay dividends. The percentage of non-payers has remained around 12% of the portfolio, the same as at the end of the last period. Given the strength of the income stream from the portfolio as a whole, we are comfortable holding some exposure to non dividend payers. 

Outlook

UK equity valuations have derated significantly and are at attractive levels relative to other regions. Within that, UK smaller companies looks very attractive relative to large companies, with the strong sector focus in the FTSE 100 Index combined with the "risk-off" trade driving significant divergence in index returns during 2022. During the last couple of months of the period the market tested some of these levels and we saw a strong bounce in UK smaller companies through October and November. With greater political stability in the UK, and also a solid degree of overseas revenue exposure within the market, we are starting to see international investors look towards their UK allocations, which have been rock bottom for some time.

We caveat this with some macro caution - we are still seeing many areas of challenge, including inflation, consumer squeeze, China supply uncertainty - and many of these factors might be testing again over the period ahead. We were not surprised to see markets retreat in December, and believe we may see that continue before there is a more sustained recovery. The war in Ukraine remains an overhang for markets, particularly given its inflationary impacts, and, for social and humanitarian reasons more than any, we would be pleased to see a peaceful resolution.

Every cycle is different, but typically in the UK we wouldn't expect to see the market recover until nearer the trough in earnings. However, many aspects of this cycle have been very different and the UK didn't enter it from peak earnings given Brexit sentiment and GDP growth relative to other regions over recent years. Therefore, there are reasons to believe that UK earnings could be nearer the trough than other geographies, and that UK markets could recover earlier in this cycle than we have often seen historically.

Meanwhile, in a recession, we think our Quality focus will prove relatively resilient. We are seeing broad areas of earnings downgrades across the market, but lots of areas of resilience and strength in the portfolio. This is the Quality focus, as well as the companies being more self-fulfilling in their growth strategies - increasingly valuable we believe when growth becomes scarcer. Lastly, with the de-rating of growth businesses through 2022, many of the Company's quality growth businesses are trading on significantly lower valuations than historically, and have been taking part strongly in the recent market recovery. This gives us some confidence over the relative performance potential of the portfolio in a market recovery,

At this early stage in a recession, we continue to believe that many cheaper value cyclical businesses will experience earnings pressures over the short term. Each cycle is different, and with the dynamics of the current environment, we would be surprised to see any market recovery over the coming period being led by the most cyclical stocks.

As we move through 2023 it remains a year of uncertainty, but we feel a lot of the most painful changes in market conditions are behind us, seen in early 2022. We would hope for a more settled environment this year, where company focus returns to markets, and share price returns are less dependent on top down macro factors.

Abby Glennie and Amanda Yeaman,
abrdn
2 March 2023

Investment Portfolio

Condensed Statement of Comprehensive Income (unaudited)

Condensed Statement of Financial Position (unaudited)

Condensed Statement of Changes in Equity (unaudited)

Condensed Statement of Cash Flows (unaudited)

Notes to the Financial Statements (unaudited)

For the year ended 31 December 2022

Alternative Performance Measures

By order of the Board

abrdn Holdings Limited

Company Secretary

2 March 2023

Please note that past performance is not necessarily a guide to the future and the value of investments and the income from them may fall as well as rise.  Investors may not get back the amount they originally invested